BiotherapyVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Protein Gives Doctors New Tool to Detect Melanoma
Posted on 07/23/2008, 14:00
By -- Robert Preidt
Excessive IMP-3, not found in harmless moles, may be key to diagnosis
WEDNESDAY, July 23 (HealthDay News) -- Melanoma produces high levels of a protein called IMP-3, which is not over-expressed in harmless moles, University of Rochester Medical Center researchers report.
They said the finding may offer doctors a new way to distinguish melanoma -- the most dangerous type of skin cancer -- from benign moles that look like melanoma.
The study was published in the current issue of Modern Pathology.
"We are very excited about our finding that IMP-3 is an important progression marker in malignant melanoma," study author Dr. Jennifer G. Pryor, a third-year resident in the department of pathology and laboratory medicine, said in a university news release.
"Although we have learned a lot about melanoma in recent years, it has unique biologic properties that sometimes make it difficult to diagnose and to plan for the proper treatment. This protein may have a key role in helping us to understand and distinguish between various types of melanocytic lesions," Pryor said.
She and her colleagues analyzed samples of 56 biopsied lesions from 48 adults. None of the benign moles over-expressed IMP-3, but excess levels of the protein were found in most melanomas.
IMP-3, which is involved in cell proliferation, appears to play a role in the formation of number of malignant tumors. Previous studies have linked expression of IMP-3 to pancreatic, ovarian and lung cancers. This new study is the first to identify a connection between the protein and melanoma.
Further research is needed to determine if more careful monitoring and aggressive treatment may benefit melanoma patients with tumors that express IMP-3.
More information
The American Academy of Dermatology has more about malignant melanoma.
SOURCE: University of Rochester, news release, July 17, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Prenatal Alcohol
Ovarian Cancer
Fire Safe Cigarettes
Christmas Colonoscopy
ER Doctors
Colonoscopy Study
Carbon Monoxide Family
Busting Diet Myths
Holiday Eating
Colon Cancer Race
Yoga and Stress
Fast Food
In the Dark
Sleep Meds

Comments (0):
Be the first to comment on this article.
Post a comment